Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality-Reference-Cited by-同舟云学术

Highly affordable vaccines are critical for our continued efforts to reduce global childhood mortality

Published:2019-05-17 Issue:11 Volume:15 Page:2660-2665
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Kaufmann Stefan H.E.¹²

Affiliation:

1. Department of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany

2. Hagler Institute for Advanced Study, College of Veterinary Medicine and College of Medicine, Texas A&M University, College Station, USA

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://tandfonline.com/doi/pdf/10.1080/21645515.2019.1605817

Reference38 articles.

1. After 2015: infectious diseases in a new era of health and development

2. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014. http://amr-review.org/Publications

3. EvaluatePharma - World Preview. 2018. Outlook to 2024, 11e – June 2018. [accessed 2019 Jan 09]. http://info.evaluategroup.com/rs/607-YGS-364/images/WP2018.pdf

4. Encouraging vaccine innovation: promoting the development of vaccines that minimize the burden of infectious diseases in the 21st century. Report to Congress, U.S. Department of Health and Human Services, Dec 2017 [accessed 2019 Jan 09]. https://www.hhs.gov/sites/default/files/encouraging_vaccine_innovation_2018_final_report.pdf.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants;npj Vaccines;2024-02-22

2. Vaccine development against tuberculosis before and after Covid-19;Frontiers in Immunology;2023-11-15

3. TikTok Content on Measles-Rubella Vaccine in Jordan: A Cross-Sectional Study Highlighting the Spread of Vaccine Misinformation (Preprint);2023-10-07

5. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months;Human Vaccines & Immunotherapeutics;2022-11-22